Feasibility of adding magnesium to intrathecal fentanyl in pediatric cardiac surgery  by Atallah, Magdy Mamdouh M. et al.
Egyptian Journal of Anaesthesia (2011) 27, 173–180Egyptian Society of Anesthesiologists
Egyptian Journal of Anaesthesia
www.elsevier.com/locate/egja
www.sciencedirect.comResearch ArticleFeasibility of adding magnesium to intrathecal fentanyl
in pediatric cardiac surgeryMagdy Mamdouh M. Atallah a,*, Hosam I. Saber a, Nabil A. Mageed a,
Abdelaziz A. Motawea a, Nawal Abdelgalil Alghareeb ba Anesthesia and Surgical Intensive Care Department, Faculty of Medicine, Mansoura University, Egypt
b Clinical Pathology Department, Faculty of Medicine, Mansoura University, EgyptReceived 2 May 2011; revised 23 June 2011; accepted 24 June 2011
Available online 30 July 2011*
C
ur
E-
de
11
an
Pe
doKEYWORDS
Intrathecal;
Fentanyl;
Magnesium;
PediatricCorresponding author. Addr
are Department, Cardiothora
a University, Egypt. Tel.: +2
mail addresses: magdyata@y
lraouf@yahoo.com (N.A. M
10-1849 ª 2011 Egyptian So
d hosting by Elsevier B.V.
er review under responsibility
i:10.1016/j.egja.2011.06.004
Production and h
Oess: Ane
cic Unit
0 502304
ahoo.com
ageed).
ciety of
of Egypti
osting by E
pen access Abstract Background: Magnesium is (NMDA) receptor antagonist used as an adjuvant for post-
operative analgesia. There are several studies comparing the efﬁcacy of the different routes of
administration of magnesium. We aimed to study the effects of adding magnesium to IT fentanyl
on peri-operative analgesic requirements after elective pediatric cardiac surgery.
Methods: This prospective double controlled randomized study (closed envelop method) included
eighty pediatric patients subjected to elective open cardiac surgery. They were randomly allocated
into four equal groups (20 patients each): (A) control group (i.v. fentanyl), (B) intrathecal fentanyl
group (ITF) (received IT 1 lg/kg of fentanyl), (C) intrathecal fentanyl and magnesium (0.5 mg/kg)
group (received IT 1 lg/kg of fentanyl citrate and 0.5 mg/kg magnesium sulfate), and (D) intrathecal
fentanyl magnesium (1 mg) group (received IT 1 lg/kg of fentanyl citrate, and 1 mg/kg magnesium
sulphate). The perioperative anesthetic management was standardized.
Results: The results of this study demonstrated that the analgesic proﬁle tended to be better with
ITF, ITF-Mg 0.5 mg/kg and ITF-Mg 1 mg/kg groups than the control group. Also, intraoperative
fentanyl used in ITF-Mg (1 mg) was statistically less as compared with ITF and ITF-Mg (0.5 mg)sthesia and Surgical Intensive
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174 M.M.M. Atallah et al.groups. Time to extubation (h) was surprisingly, shorter in ITF-Mg (1 mg) as compared with ITF
and control groups. Also, postoperative intravenous fentanyl consumption lg/kg/24 h was more in
control group as compared with other groups.
Conclusion: In conclusion, the use of intrathecal fentanyl-magnesium (1 mg/kg) in pediatric patients
subjected to open cardiac surgery reduced intra and postoperative analgesic consumption, prolonged
the time to ﬁrst analgesic requirement and allowed early tracheal extubation when compared with
intravenous fentanyl, intrathecal fentanyl or intrathecal fentanyl-magnesium (0.5 mg/kg).
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Several retrospective studies concerning the feasibility of an
early extubation approach in pediatric cardiac patients were
published, including patients at high risk for a complicated
perioperative course [1,2]. The advantages of this approach
may be primarily related to the avoidance of adverse effects
of prolonged mechanical ventilation and lower hospitalization
costs related to shorter ICU and hospital stay [2].
Intrathecal (IT) morphine has delayed the onset of action
and may cause delayed extubation after cardiac surgery be-
cause of prolonged ventilatory depression [3]. On the contrary,
lipid-soluble opioids such as fentanyl and sufentanil have a ra-
pid onset but shorter duration of action [4].
Magnesium has antinociceptive effects in animal and human
models [5]. These effects are primarily based on the regulation
of calcium inﬂux into the cell, which is natural physiological
calcium antagonism, and antagonism of the N-methyl-D-aspar-
tate (NMDA) receptor [6]. There are some studies comparing
the efﬁcacy of the different routes of administration of magne-
sium, such as i.v., IT, or epidural and its effect on anesthetic
and analgesic quality. Intravenous magnesium, even high
doses, is associated with limited passage across the blood–brain
barrier [7,8]. Studies in humans in which IT magnesium was gi-
ven to various groups of patients found that none had symp-
toms suggestive of neurotoxicity, nor did they exhibit signs of
systemic toxicity such as hypotension, dysrrhythmia, somno-
lence or weakness, and even on long term follow up [9–13].
Buvanendran et al. (2002) found that intrathecal 50 mg
magnesium prolongs spinal fentanyl analgesia during labor
and suggested that the availability of an intrathecal NMDA
antagonist could be of clinical importance for pain manage-
ment [9]. Also, Bilir et al. (2007) found that co-administration
of epidural magnesium for postoperative epidural analgesia
provided a pronounced reduction in patient-controlled epidu-
ral fentanyl consumption without recorded side-effects [7].
This study hypothesized that preoperative administration of
IT fentanyl, and magnesium in different doses in pediatrics
undergoing open heart surgery for congenital heart diseases
may facilitate the weaning from CPB, improve the quality of
postoperative analgesia, decrease stress response and shorten
the extubation time. The aim of this study is to compare the ef-
fects of both IT fentanyl and IT fentanyl-magnesium in two dif-
ferent concentrations on peri-operative analgesic requirements,
weaning from cardiopulmonary bypass, stress response and the
extubation time in elective pediatric cardiac surgery.
2. Materials and methods
After approval of the local ethical committee of Anesthesia
And Surgical Intensive Care Department, Mansoura Univer-sity, this prospective double controlled randomized study
(using closed envelop method) was conducted on 80 patients
of either sex, aged 4–14 years submitted for elective cardiac sur-
gery (VSD, ASD, Subaortic membrane) from 2007 to 2010
using CPB at Pediatric Cardiac Surgery Unit in Children
Hospital, Mansoura University. All parents of the patients
signed written informed consent prior to enrollment after
explanation.
Exclusion criteria include: coagulopathy, platelet count
<100,000/mm3, and the recent use of anticoagulant drugs.
Also, redo surgery, heart block, pulmonary hypertension,
preoperative impaired left ventricular ejection fraction
<40% were excluded. Patients with signs of interstitial or alve-
olar edema on chest X-ray, body mass index >35 kg m2,
preoperative serum creatinine >1.5 mg/dl, hypo and hyper-
magnesemia were also excluded from the study. Known or
anticipated difﬁcult airway, scoliotic spines, myopathies, cur-
rent use of clonidine or steroids (for their possible confounding
effects on postoperative analgesia), and any known contraindi-
cation to spinal anesthetic administration were not included.
All patients were subjected to preoperative clinical exam-
ination for assessment of cardiovascular function. Labora-
tory investigations including CBC, electrolytes analysis;
ABGs, urine analysis, and coagulation survey were done.
Blood glucose level, liver and renal function tests were tested.
Radiological work, ECG and echocardiographic investiga-
tions were fulﬁlled. Patients were randomly classiﬁed using
closed envelop method into four equal groups: A – Control
group: (n= 20) no intrathecal drugs. B – ITF (fentanyl)
group: (n= 20) intrathecal fentanyl 1 lg/kg. C – IT fenta-
nyl-magnesium (0.5 mg/kg) group: (n= 20) intrathecal fenta-
nyl 1 lg/kg with magnesium sulfate 0.5 mg/kg. D – IT
fentanyl-magnesium (1.0 mg/kg) group]: (n= 20). Intrathecal
fentanyl 1 lg/kg with magnesium sulfate 1 mg/kg. In All
Groups anesthesia was maintained with both isoﬂurane and
intravenous fentanyl. All injectate was given 0.15 ml/kg as
whole volume in preservative free sterile water up to maxi-
mum volume 4 ml regardless to more body weight. All chil-
dren fasted according to the fasting protocol with age for at
least 4 h before the surgery. All patients were pre-medicated
in the preoperative area with I.M. 0.05 mg/kg midazolam
and 0.015 mg/kg atropine sulfates 15 min before induction
of general anesthesia. Five leads ECG, peripheral oxygen sat-
uration [SpO2] and non-invasive blood pressure [NIBP] were
monitored. Supplemental oxygen was provided via a face
mask. Peripheral intravenous indwelling cannula was inserted
one hour after application of EMLA cream.
In all groups, Anesthesia was induced by slow i.v. adminis-
tration of fentanyl 10 lg/kg, propofol 1–2 mg/kg, and 0.1 mg/
kg vecuronium to provide neuromuscular blockade and
facilitate tracheal intubation. With loss of consciousness, posi-
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20–28 breathings per minute. Patients were intubated orally
with an appropriately sized endotracheal tube such that no
audible air leak was present below 35 cm H2O peak inspiratory
pressures.
Patients were mechanically ventilated with 100% O2 and
the end-tidal CO2 was monitored by main-stream capnogram
and maintained between 30 and 35 mmHg.
Anesthesia was maintained with isoﬂurane, incremental
0.02 mg/kg doses of vecuronium to maintain muscle relaxation
and additional i.v. boluses of fentanyl (1 lg/kg) were given if
blood pressure and heart rate increased (>25% above base-
line) and it was assumed that the increases were due to insuf-
ﬁcient depth of anesthesia, hypotension was considered
clinically signiﬁcant when systolic arterial blood pressure dif-
fered by more than 25% compared with the baseline values
for more than 1 min and was treated with intravenous ﬂuids
and, when indicated, incremental doses of ephedrine, while
bradycardia was considered clinically signiﬁcant when heart
rate decreased by more than 25% compared with baseline val-
ues for more than 1 min and was treated with atropine
intravenously.
A radial artery catheter (22–24 G) was inserted, after per-
formance of a modiﬁed Allen’s test in the non dominant hand,
to monitor the arterial blood pressure and blood gases sam-
pling during the entire procedure. A urinary catheter was
placed to monitor urine output. Also, rectal and nasopharyn-
geal temperatures were continuously monitored; an appropri-
ate size central venous catheter was inserted under complete
aseptic conditions for central venous pressure monitoring
[insertion done after intrathecal injection to allow maximum
time (more than 60 min) between intrathecal and heparin
injection].
The patient was placed in the right lateral decubitus posi-
tion. The skin over the injection area was cleaned with chlo-
rohexidine 0.5% containing solution, which was allowed to
dry. Then, using a sterile technique a 2-inch, 25-gauge Quinc-
ke spinal needle was inserted at L3–4 or L4–5. Successful
dural puncture was conﬁrmed by observation of a free ﬂow
of cerebrospinal ﬂuid, and the injection was performed with
the bevel of the needle oriented in the cephalic direction
and the table turned with head up position for 5 min [hypo-
baric solution (speciﬁc gravity measured for different
injectant solution using combitest strips and was about
1000–1005 for fentanyl in water and about 1005 for both fen-
tanyl-0.5 mg magnesium and fentanyl-1 mg magnesium)] to
get high level (the injectate was unknown to the anesthetist
in charge, monitoring done by the anestheist out of the study,
and randomization was done through closed envelop
method).
H.R, MAP, CVP, EtCO2, SpO2, nasopharyngeal and rectal
temperatures, arterial blood gases and electrolytes (Na and K),
were recorded at the following time intervals: Before induction
of general anesthesia (baseline), after induction, after skin inci-
sion, after sternotomy, and then each 15 min after discontinu-
ation of cardiopulmonary bypass. Hypertension and
hypotension were considered clinically signiﬁcant when sys-
tolic arterial pressure differed by more than 25% compared
with baseline values for more than 1 min. Bradycardia was
considered clinically signiﬁcant when heart rate decreased by
more than 25% compared with baseline values for more than
1 min. ACC (minutes), CPB (minutes), spontaneous recoveryof the heart, need for DC shocks and the inotropes ± dila-
tors/vasopressors or support to wean the heart from CPB were
recorded in all the patients.
After surgery, patients were transferred to the ICU,
where they were monitored by the other team who were
blinded to the anesthetic protocol that had been used. In
the ICU. H.R, MAP, CVP were recorded at one hour inter-
vals after admission to ICU, for 12 h, then every 2 h for
24 h.
Post – extubation hourly pain score was assessed using
objective pain discomfort score (10 points scale; where
0 = no pain & 10 = maximum pain) in children for 12 h [14].
Bromage score, was assessed after extubation and graded
as: I – Free movement of legs and feet [Nil (0%)], II – Just able
to ﬂex knees with free movement of feet [Partial (33%)], III –
Unable to ﬂex knees, but with free movement of feet, [Almost
complete (66%)], IV – Unable to move legs or feet [Complete
(100%)].
Extubation time and the need for reintubation were
recorded. Criteria for extubation included a responsive and
cooperative patient, negative inspiratory force of >20 cm
H2O, vital capacity >10 ml/kg, PaO2 >80 mmHg with frac-
tion of inspired oxygen <0.5, pH >7.3, core temperature
>36.5 C, hemodynamic stability, limited chest tube
drainage and no uncontrolled dysrrhythmia. First request
for analgesic requirement and the total dose of analgesic
consumption [i.v. fentanyl lg/kg], the length of ICU and
hospital stays were recorded. Neurological evaluation was
done on a daily basis to exclude any signs of neurologi-
cal abnormality. Incidence of nausea, vomiting,
retention, or pruritus, as signs of opioid side effects was
recorded.
In this study, the Stress response to surgery and CPB was
determined by changes in serum cortisol, and blood glucose
concentrations. Venous blood samples were collected at four
times: preoperatively, 5 min after sternotomy, 1 and 24 h after
CPB. These times were based on likely physiological responses
over time and local economic limitations. The blood samples
were centrifuged and serum was drawn off and was stored at
4 C until assayed within 2 weeks of collection. Serum cortisol
levels were determined using a radioimmunoassay technique
(Streptavidin Coated microparticles). The sensitivity (Lower
detection limit) is 0.018 lg/dL (0.5 nmol/dL) and the coefﬁ-
cient of variation 9%.
Serum magnesium level was measured preoperative (24 h
before surgery) to make sure normal serum level and postoper-
ative (6 h after surgery to decrease hemodilution effect of CPB
priming), to exclude any systemic effect of intrathecally given
magnesium.
The statistical analyzes of data were done by using excel
program and SPSS (SPSS, Inc, Chicago, IL.) program statis-
tical package for social science version 10. Data distribution
K-S (Kolmogorov-Smirnov) test was used to test signiﬁcant
nonparametric data. The analysis of the data was done to test
statistical signiﬁcant difference between groups. ONE WAY
ANOVA test to compare more than two groups, followed by
Post Hoc test LSD (least signiﬁcant difference) for inter groups
comparisons. For quantitative data student t-test was used.
Paired sample t-test was done to compare signiﬁcance in one
group at different times. Chi square test was used for qualita-
tive data. P value was considered signiﬁcant if <0.05 at conﬁ-
dence interval 95%.
Table 1 Patient’s characteristics in the studied groups. Data are expressed as mean ± SD and number.
Control group
(n= 20)
ITF group
(n= 20)
ITF-Mg (0.5 mg) group
(n= 20)
ITF-Mg (1 mg) group
(n= 20)
Age (year) 6.28 ± 1.94 5.04 ± 0.51 5.86 ± 1.34 5.91 ± 1.62
Body mass index
(kg/m2)
18.33 ± 5.18 22.13 ± 6.04 17.40 ± 4.09 19.53 ± 6.89
Gender (M/F) 12/8 13/7 11/9 13/7
Surgical procedure
ASD 10 11 9 10
VSD 8 8 9 8
Subaortic
membrane
2 1 2 2
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Table 1 showed the patients demographics of the four studied
groups, control group (i.v.), ITF group, ITF-Mg (0.5 mg)
group, and ITF-Mg (1 mg) group, there were no signiﬁcant
differences between the four groups as regards age, body mass
index (BMI), male to female ratio and the type of surgical
procedure.
In this study intraoperative parameters, [ACC (min), CPB
(min), lowest temperature on CPB (C), and operative time
(min)] showed no signiﬁcant differences between the four
groups but the total dose of intraoperative i.v. fentanyl used
was signiﬁcantly less in ITF group, ITF-Mg (0.5 mg) group,
and ITF-Mg (1 mg) group when compared with the control
group (15.60 ± 2.84 in ITF, 14.40 ± 2.02 in ITF-Mg
(0.5 mg), 11.26 ± 1.38 in ITF-Mg 1 mg, as compared with
18.06 ± 2.43 in control group). Also, Intraoperative fentanylTable 2 Intraoperative variables in the studied groups. Data are ex
Control group
(n= 20)
ACC (min) 29.00 ± 6.81
CPB (min) 43.00 ± 6.72
Minimum temperature on CPB (C) 32.06 ± 1.75
Surgical time (min) 146.13 ± 11.32
Total Intraoperative IV fentanyl used (lg/kg) 18.06 ± 2.43
P< 0.05 is signiﬁcant.
ACC: Aortic cross clamp time.
CPB: Cardiopulmonary bypass time.
* Signiﬁcant when compared with control group.
 Signiﬁcant when compared with ITF and ITF-Mg (0.5 mg) groups.
Table 3 Weaning off CPB parameters in the studied groups. Data
Control group (n= 20) ITF group (n=
Spontaneous recovery of heart 19 (95%) 18 (90%)
DC shock 1 (5%) 2 (10%)
Dopamine use 7 (35%) 6 (30%)
Dopamine dose (lg/kg/min) 5 ± 1.9 6 ± 1.2
Nitro-glycerin use 20 (100.0%) 20 (100.0%)
Nitroglycerine dose (lg/kg/min) 2.76 ± 1.29 2.83 ± 1.33used was signiﬁcantly less in group ITF-Mg (1 mg) as com-
pared with ITF group, and ITF-Mg (0.5 mg) group (Table 2).
In this study, no signiﬁcant differences between the four
groups as regard to criteria of weaning from CPB (Table 3).
Most of the patients in the four groups were extubated early
(within 6 h). However, the number of patients, who fulﬁlled
the extubation criteria in the operating room was signiﬁcantly
more in the ITF-Mg (1 mg) group (6 patients) when compared
with the other groups (none) as, time to extubation (h) was
shorter in ITF-Mg (1 mg) as compared with ITF and control
groups (1.84 ± 0.57 in ITF-Mg 1 mg, 4.80 ± 1.43 in control,
and 4.10 ± .84 in ITF groups) (Table 4). Also, time to 1st
analgesic requirement (h) was shorter in control group when
compared with other groups (7.30 ± 2.02 in ITF,
8.42 ± 2.04 in ITF-Mg 0.5 mg, 10.33 ± 5.36 in ITF-Mg
1 mg, and 2.86 ± 1.64 in control groups), and it was statisti-
cally longer in ITF-Mg (1 mg) as compared with ITF andpressed in mean ± SD.
ITF group
(n= 20)
ITF-Mg (0.5 mg)
group (n= 20)
ITF-Mg (1 mg)
group (n= 20)
27.00 ± 5.41 29.26 ± 12.61 29.53 ± 7.18
44.06 ± 7.77 44.40 ± 16.07 45.26 ± 9.39
32.26 ± 1.79 31.66 ± 1.79 32.13 ± 1.50
147.33 ± 9.50 146.07 ± 11.51 149.93 ± 10.50
15.60 ± 2.84* 14.40 ± 2.02* 11.26 ± 1.38*, 
are expressed in mean ± SD, number (percentage).
20) ITF-Mg (0.5 mg) group (n= 20) ITF-Mg (1 mg) group (n= 20)
18 (90%) 19 (95%)
2 (10%) 1 (5%)
6 (30%) 8 (40%)
5 ± 1.6 5 ± 2
20 (100.0%) 20 (100.0%)
2.66 ± 1.34 2.80 ± 1.26
Table 4 Postoperative variables in the studied groups. Mean ± SD, number (%).
Control group
(n= 20)
ITF group
(n= 20)
ITF-Mg (0.5 mg)
group (n= 20)
ITF-Mg (1 mg)
group (n= 20)
O.R. extubation 0 0 3 (15%) 6 (30%) #
Extubation time (h) 4.80 ± 1.43 4.10 ± .84 3.69 ± 1.18 1.84 ± 0.57#
Time to 1st analgesic
requirement (h)
2.86 ± 1.64 7.30 ± 2.02* 8.42 ± 2.04* 10.33 ± 5.36* 
Postoperative fentanyl
consumption lg/kg/24 h
7.06 ± 2.31 4.93 ± 2.37* 4.66 ± 2.09* 3.76 ± .97*
ICU length of stay (h) 32.60 ± 3.26 31.80 ± 3.50 30.60 ± 3.54 30.33 ± 3.99
hospital length of stay (days) 6.13 ± .63 5.80 ± .67 5.80 ± .67 5.80 ± .67
Nausea and Vomiting 2 (10%) 2 (10%) 1 (5%) 1(5%)
Pruritus 0 0 0 0
Neurologic deﬁcit 0 0 0 0
Bromage score I I I I
P< 0.05 is signiﬁcant.
* Signiﬁcant when compared with control.
 Signiﬁcant when compared with ITF and ITF-Mg (0.5 mg) groups.
# Signiﬁcant when compared with control and ITF groups.
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nyl consumption lg/kg/24 h, it was more in the control group
as compared with other groups (4.93 ± 2.37 in ITF,
4.66 ± 2.09 in ITF-Mg (0.5 mg), 3.76 ± .97 in ITF-Mg
(1 mg), and 7.06 ± 2.31 in control group There were no signif-
icant differences between the four groups as regards ICU and
hospital length of stay. There were no signiﬁcant differences
between the four groups as regard to postoperative Bromage
score and adverse effects as nausea and vomiting, pruritus,
and neurologic deﬁcit (Table 4).
Table 5 shows laboratory evaluation of the stress response
(serum cortisol and blood glucose) and serum magnesium.
There were no signiﬁcant differences between the four groups
in serum cortisol and blood glucose at different stages of eval-
uation, but there were signiﬁcantly high serum cortisol and
blood glucose at 1 h after termination of CPB when compared
with their basal values in the four groups (Table 5). There were
no signiﬁcant differences between preoperative and postopera-
tive serum magnesium levels (Table 5).Table 5 Laboratory evaluation [serum cortisol (lg/dl), blood g
Mean ± SD.
Control group (n= 20) ITF group (n= 20)
Serum cortisol (lg/dl)
Basal 14.82 ± 3.18 15.14 ± 5.33
Post sternotomy 15.22 ± 4.52 17.76 ± 4.56
1 h post CPB 59.28 ± 16.60* 57.08 ± 13.78*
24 h postoperative 16.41 ± 8.11 17.27 ± 7.00
Blood glucose (mg/dl)
Basal 79.26 ± 5.03 79.40 ± 5.74
Post sternotomy 117.33 ± 6.94 115.13 ± 6.34
1 h post CPB 206.13 ± 11.89* 213.27 ± 12.63*
24 h postoperative 81.86 ± 5.40 82.33 ± 5.82
Serum Mg+2 (mg/dl)
Preoperative 1.50 ± .58 1.34 ± .42
Postoperative 1.43 ± .53 1.31 ± .36
P< 0.05 is signiﬁcant.
* Signiﬁcant when compared with their basal value.In this study, postoperative objective pain discomfort score
was signiﬁcantly lower in the ITF-Mg (1 mg) group in the early
postoperative period when compared with the other groups
(Table 6).
In the current study, the mean arterial blood pressure (Ta-
ble 7) and heart rate (Table 8) were signiﬁcantly lower in the
ITF-Mg (1 mg) group intraoperatively and early postopera-
tively when compared with the other groups. Also, there were
no signiﬁcant differences between the four groups as regards
the perioperative central venous pressure, SaO2, PaO2 and
PaCO2.
4. Discussion
The results of this study demonstrated that the use of intrathe-
cal fentanyl/magnesium (1 mg/kg) in pediatric patients sub-
jected to elective open cardiac surgery provided superior
hemodynamic stability, reduced intra and postoperative anal-
gesic consumption, prolonged the time to ﬁrst analgesiclucose (mg/dl), serum Mg+2 (mg/dl)]. Data are expressed in
ITF-Mg (0.5 mg) group (n= 20) ITF-Mg (1 mg) group (n= 20)
15.20 ± 4.07 15.52 ± 4.18
15.35 ± 4.13 14.45 ± 4.78
60.92 ± 9.74* 61.78 ± 6.41*
18.12 ± 6.42 17.82 ± 3.75
79.60 ± 5.48 78.26 ± 5.92
111.47 ± 5.76 110.80 ± 6.48
207.40 ± 14.48* 202.13 ± 27.86*
80.40 ± 5.35 79.86 ± 5.33
1.36 ± .48 1.47 ± .48
1.27 ± .46 1.40 ± .37
Table 6 Postoperative pain score in the studied groups. Data are expressed in median (range).
Control group (n= 20) ITF group (n= 20) ITF-Mg (0.5 mg) group (n= 20) ITF-Mg (1 mg) group (n= 20)
After 1 h 5(3–7) 5(3–8) 5(3–7) 2(0–5)*
After 2 h 4(3–6) 4(3–6) 4(3–5) 2(0–4)*
After 3 h 4(3–6) 4(1–5) 4(1–5) 2(0–4)*
After 4 h 4(2–5) 4(1–5) 3(1–5) 1(1–4)*
After 5 h 4(2–5) 4(1–5) 3(1–4) 2(1–3)*
After 6 h 4(2–5) 3(0–5) 3(0–5) 2(1-3)*
After 7 h 4(2–5) 3(1–4) 3(1–4) 1(0-3)*
After 8 h 3(2–5) 3(1–5) 3(2–4) 2(0–3)*
After 9 h 3(2–4) 3(0–5) 3(1–5) 1(0–3)*
After 10 h 3(2–5) 3(0–5) 2(0–4) 1(0–2)*
After 11 h 3(2–4) 3(0–4) 2(0–4) 1(0–2)*
After 12 h 3(2–4) 3(0–4) 2(0–4) 1(0-2)*
P< 0.05 is signiﬁcant
* Signiﬁcant when compared with control, ITF and ITF-Mg (0.5 mg) groups.
Table 7 Perioperative MAP (mmHg) in the studied groups. Data are expressed in mean ± SD.
Control group (n= 20) ITF group (n= 20) ITF-Mg (0.5 mg) group (n= 20) ITF-Mg (1 mg) group (n= 20)
Basal 70.80 ± 5.15 71.46 ± 4.54 70.66 ± 4.83 70.33 ± 3.26
Intraoperative
Post induction 81.86 ± 5.01 80.73 ± 6.95 79.73 ± 5.04 82.00 ± 5.00
After skin incision 80.46 ± 5.39 78.00 ± 5.95 79.13 ± 5.16 75.20 ± 4.27*
Post sternotomy 82.46 ± 4.38 77.66 ± 5.36 78.66 ± 4.13 72.93 ± 3.76*
30 min post CPB 81.33 ± 4.32 77.73 ± 5.89 76.20 ± 5.89 70.80 ± 4.76*
60 min post CPB 83.00 ± 5.05 76.86 ± 6.41 77.13 ± 5.15 72.00 ± 5.87*
Postoperative
After 1 h 82.86 ± 5.11 78.86 ± 6.77 77.73 ± 4.81 71.80 ± 5.47*
After 6 h 80.66 ± 6.60 79.00 ± 6.67 78.40 ± 5.09 74.20 ± 5.93*
After 12 h 79.33 ± 6.44 79.86 ± 5.97 79.86 ± 5.48 75.06 ± 5.61
P< 0.05 is signiﬁcant.
* Signiﬁcant when compared with control group.
Table 8 Perioperative HR (beats/min) in the studied groups. Data are expressed in mean ± SD.
Control group (n= 20) ITF group (n= 20) ITF-Mg (0.5 mg) group (n= 20) ITF-Mg (1 mg) group (n= 20)
Basal 106 ± 5 105 ± 8 106 ± 7 106 ± 6
Intraoperative
Post induction 115 ± 4 113 ± 6 115 ± 4 109 ± 22
After skin incision 119 ± 26 117 ± 8 119 ± 7 115 ± 5
Post sternotomy 122 ± 4 118 ± 7 117 ± 6 111 ± 4*
30 min post CPB 126 ± 7 120 ± 7 116 ± 8 113 ± 6*
60 min post CPB 129 ± 5 121 ± 6 120 ± 9 115 ± 8*
Postoperative
After 1 h 128 ± 10 120 ± 7 121 ± 9 114 ± 7*
After 6 h 125 ± 8 121 ± 6 119 ± 11 114 ± 7*
After 12 h 125 ± 7 121 ± 6 121 ± 6 119 ± 8
P< 0.05 is signiﬁcant.
* Signiﬁcant when compared with control.
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with intravenous fentanyl, intrathecal fentanyl or intrathecal
fentanyl/magnesium (0.5 mg/kg) but did not affect the stress
response to CPB.
In this study, the analgesic proﬁle was better with ITF, ITF-
Mg 0.05 mg/kg and ITF-Mg 1 mg/kg groups than the controlgroup in pediatric patients undergoing cardiac surgery. As
these groups were associated with less total intraoperative
i.v. fentanyl used, less postoperative analgesic requirements
(Postoperative fentanyl consumption lg/kg/24 h) and pro-
longed time to 1st analgesic requirement when compared with
the control group. More speciﬁcally, intraoperative fentanyl
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ITF and ITF-Mg (0.5 mg) groups. Also, time to 1st analgesic
requirement is prolonged in ITF-Mg (1 mg)/group as com-
pared with ITF and ITF-Mg 0.05 mg/kg groups. This is in
accordance with earlier clinical human investigations, which
reported increased duration of analgesia with intrathecal mag-
nesium in various obstetric and non-obstetric populations
[9,13]. Also, another study found that the addition of MgSO4
to spinal anesthesia prolonged the time to ﬁrst analgesic
requirement, but did not reduce total analgesic consumption
in the ﬁrst 24 h [10].
In another study, Pirat et al. [15] compared cardiovascular
and neurohumoral responses associated with I.T. fentanyl
(2 lg/kg) in ﬁrst group, i.v. (10 lg/kg followed by an i.v. infu-
sion of 10 lg/kg/h) in second group, and third group using a
combination of both regimens in pediatric patients undergoing
cardiac surgery. They found that patients receiving a combina-
tion of both i.v. and IT fentanyl had less hemodynamic re-
sponse to sternotomy than in either of the other groups. This
study showed that the three groups (IV, IT, combined IV+IT)
required approximately similar amounts of additional fentanyl
during the operation, also there were no signiﬁcant differences
among the groups with respect to postoperative analgesic
requirement. This study may conﬁrm the advantage of adding
Magnesium IT to fentanyl, and its analgesic effect based on
our analgesic proﬁle in pediatric patients subjected to cardiac
surgery.
In the current study, all patients in the four groups were
extubated early (less than 6 h), however, the number of pa-
tients who were extubated in the operating room was, signiﬁ-
cant more in the ITF-Mg (1 mg) group than other groups.
This may be attributed to less intraoperative fentanyl used in
this group, and hence less central respiratory depressant effect
as explained by other studies [16]. The time to extubation was
shorter in the ITF-Mg (1 mg) group than other groups and,
also this may be explained by the decrease in the total intraop-
erative intravenous fentanyl used in these groups
(18.06 ± 2.43 lg/kg in the control group, 15.60 ± 2.84 lg/kg
in ITF group, 14.40 ± 2.02 lg/kg in ITF-Mg 0.5 mg/kg group
and 11.26 ± 1.38 lg/kg in ITF-Mg 1 mg/kg group).
In contrast, Pirat et al. [15] cannot explain the signiﬁcantly
shorter extubation times in pediatric cardiac surgery that were
recorded for Group IT + i.v., although using high dose of
intravenous fentanyl (49.7 ± 6.1 lg/kg). However, this may
be explained by short duration of action of fentanyl, strong
tendency of fentanyl to bind to the surfaces of the CPB circuit,
hemodilution and drug sequestration, which further decrease
the plasma concentration of fentanyl.
Also, Davis et al. [17] deﬁned intraoperative variables pre-
dictive of early extubation, as CPB time, aortic cross clamp
time (ACC) and circulatory arrest time. These variables were
of short time in our study, and hence enabled short extubation
time in our study as compared with other studies with pro-
longed CPB, ACC, and circulatory arrest time.
The present study showed no signiﬁcant differences as re-
gards ICU and hospital length of stay. We found no signiﬁcant
hemodynamic effect (hypotension) following the addition of
magnesium to our spinal solution and addition of intrathecal
magnesium to fentanyl provides hemodynamic stability. This
may be attributed to the absence of systemic vasodilator effects
of spinal magnesium in this dose and this was shown in normal
Mg+2 serum level in the postoperative values.As regards the stress response to cardiac surgery, we used
serum cortisol and blood glucose as hormonal and metabolic
indicators of the stress response. The four groups showed sig-
niﬁcantly higher serum cortisol and blood glucose levels at one
hour after CPB when compared with the basal values. These
ﬁndings concur with the results of another study [15] and are
believed to be related to several factors as, systemic inﬂamma-
tory response, hypotension, and hypothermia associated with
CPB, independent of the used opioid dose. These results indi-
cated that the above four mentioned anesthetic regimens were
not enough to blunt stress response.
Considering respiratory depression, pruritus, nausea and
vomiting all of which are well recognized adverse effects of
spinal opioid usage. There were no reported cases as regard
to incidence of respiratory depression in all studied groups
(as the postoperative arterial blood gases showed neither sig-
niﬁcant hypoxemia nor hypercapnia in the 4 groups). As re-
gard to nausea and vomiting, it was minimal self limiting
problem, and didn’t require treatment.
This may be explained by the pharmacokinetics of fentanyl,
which is a lipid-soluble opioid, binds fairly rapidly with the
opioid receptors in the dorsal horn of the spinal cord leaving
only small amounts of substance for cephalad migration to
the fourth ventricle, and chemoreceptor trigger zone, in con-
trast with the less lipid-soluble morphine [18].
This is in accordance with the result of Pirate et al. [15] who
found no problems with these adverse effects on similar group
of patients although using larger doses of fentanyl both intra-
thecal and intravenous.
Varassi et al. [19] reported that the subarachnoid adminis-
tration of 25 lg of fentanyl during spinal anesthesia in non-
premedicated men did not cause early respiratory depression
in elderly patients. An increased risk of respiratory depression
in laboring parturient has been reported with systemic MgSO4
therapy [20]. An increased incidence of respiratory depression
may be expected when these two drugs are neuroaxially com-
bined; however, we did not observe this in this study, and this
in accordance with other studies that investigate neuroaxial
magnesium [9,10,13], all of these studies proved that absence
of respiratory depressant effect of neuroaxial magnesium.
Urinary retention is another side effect of intrathecal opi-
oids, we recorded no cases of urinary retention because all pa-
tients had a urinary catheter in place inserted before surgery,
remained in place in the ICU. However, no reported retention
was recorded after the catheter removal.
In this study, there was no neurological deﬁcit, or signs sug-
gestive of epidural hematoma, nerve compression or neurotox-
icity even on long term follow up (up to 2 months), the absence
of epidural hematoma may be due to use of a 25-gauge spinal
needle inserted at L3–4 or L4–5 approximately one hour be-
fore administration of heparin and this coincides with another
studies [15,17,21].
The current study showed no signiﬁcant differences be-
tween the studied groups in the criteria of weaning off CPB
as regards the spontaneous recovery of the heart, the need
for DC shocks for deﬁbrillation and the need for inotropes
or vasodilators. This may be explained by other studies that re-
ported that myocardial injury in pediatric cardiac surgery in
infants and children was dependent on age and ischemic time
and type of surgical procedure [22]. Also previous ventricular
function determines the need for inotropic support during
weaning off CPB [23]. Since that the age, type of surgical
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the four studied groups, there were no signiﬁcant differences in
the weaning parameters between the studied groups. Thus, this
study indicated that weaning off CPB was not affected by
intrathecal fentanyl or intrathecal fentanyl-magnesium.
The present study showed that heart rate and mean arterial
blood pressure both intra and post operatively were signiﬁ-
cantly lower in intrathecal fentanyl-magnesium 1 mg/kg group
than the control group. The explanation for this is that spinal
opioids may only attenuate increased sympathetic nerve activ-
ity elicited by myocardial ischemia in patients undergoing car-
diac surgery [24] and addition of magnesium had synergistic
effects to spinal opioid in this dosage.
The current study indicates that preoperative administra-
tion of intrathecal fentanyl-magnesium 1 mg/kg in pediatric
patients submitted to open heart surgery for congenital heart
repair provided lower pain scores in the early postoperative
period with subsequent lower dosages of fentanyl consumed
postoperatively when compared with the control group. Be-
cause no published study has assessed the effectiveness of
intrathecally injected MgSO4 in preventing postoperative pain
in pediatric cardiac surgery, no reported data are available for
comparison.
In conclusion, the use of intrathecal fentanyl-magnesium
(1 mg/kg) in pediatric patients subjected to open cardiac sur-
gery provided superior hemodynamic stability, reduced intra
and postoperative analgesic consumption, prolong the time
to ﬁrst analgesic request and allows early tracheal extubation
when compared with intravenous fentanyl, intrathecal fentanyl
or intrathecal fentanyl-magnesium (0.5 mg/kg).
Further studies are recommended in which different doses
of magnesium are to be used, including a large number of pa-
tients, and long term follow up for subsequent years. The ab-
sence of any adverse hemodynamic effects or prolonged
respiratory depression after IT fentanyl-magnesium adminis-
tration is encouraging and suggests that further studies involv-
ing larger doses of IT fentanyl-magnesium may be of value.
Despite the promise that IT administration may offer, the po-
tential beneﬁts of such an invasive procedure must always be
weighed against the potential risks.
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